Immunological markers of rheumatoid arthritis

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2016, Vol 70, Issue

Abstract

Rheumatoid arthritis (RA) is the most common connective tissue disease of autoimmune origin. The disease is characterized by chronic inflammation leading to bone erosions and organ involvement. RA is a progressive disease. It affects the quality of life, leading to disability and death mainly due to premature cardiovascular disease. Early diagnosis and appropriate treatment are essential for prognosis and quality of life improvement.In 2010 the American College of Rheumatology (ACR) and The European League Against Rheumatism (EULAR) established new RA classification criteria. Besides clinical symptoms it includes two immunologic criteria: rheumatoid factor (RF) and anti-citrullinated protein antibodies (anti-CCP antibodies). RF is the first well-known RA immunologic marker. It is observed in 80-85% of patients with RA. Elevated serum level of RF has been associated with increased disease activity, radiographic progression, and the presence of extraarticular manifestations. The sensitivity of RF is 50-90%, and specificity is 50-95%. Anti-CCP antibodies appear to be a more specific marker than RF. They are often present at the very beginning of the disease, or even years before the first symptoms. The prognostic value of anti-CCP antibodies is well established. High serum level of anti-CCP correlates with poor prognosis and early erosions of the joints. The sensitivity of anti-CCP2 is 48-80%, and specificity is 96-98%.New immunologic markers include anti-carbamylated protein antibodies (anti-CarP) and antibodies against heterogeneous nuclear ribonucleoproteins (anti-hnRNP A2/B1, RA33). Scientists aim to identify a highly sensitive and specific biomarker of the disease that not only has diagnostic and prognostic value but also may predict the response to treatment.

Authors and Affiliations

Agnieszka Matuszewska, Marta Madej, Piotr Wiland

Keywords

Related Articles

Pro-angiogenic cytokines in systemic sclerosis

Systemic sclerosis (SSc) is a multifactorial connective tissue disease characterized by excessive and progressive fibrosis along with microvasculopathy due to poor vascular formation and repair. Despite a general increas...

The role of ceramides in selected brain pathologies: ischemia/hypoxia, Alzheimer disease

Ceramides, members of the sphingolipids, are produced in the central nervous system by de novo synthesis, sphingomyelin hydrolysis or the so-called salvage pathway. They are engaged in formation of lipid rafts that are...

Menopause, obesity, and bone status

Recent studies indicate that obesity is not a risk factor of osteoporosis. On the contrary, increased adipose tissue mass may have a protective effect against osteoporosis. This suggests that the positive influence of ad...

Molekularna charakterystyka oraz fizjologiczne znaczenie DOPA-dekarboksylazy

DOPA-dekarboksylaza jest jednym z istotnych elementów układu dopaminergicznego mózgu oraz sytemu wychwytu i dekarboksylacji prekursorów amin w tkankach obwodowych. Oprócz amin katecholowych, enzym DDC odpowiada za biogen...

Identification of circulating tumor cells as a promising method of genitourinary cancer diagnosis

Circulating tumor cells (CTCs) are cells circulating in the blood, which in terms of antigenic or genetic profile correspond to a particular type of cancer. It is suspected that CTCs possess properties of cancer stem cel...

Download PDF file
  • EP ID EP220745
  • DOI -
  • Views 165
  • Downloads 0

How To Cite

Agnieszka Matuszewska, Marta Madej, Piotr Wiland (2016). Immunological markers of rheumatoid arthritis. Advances in Hygiene and Experimental Medicine, 70(), 251-257. https://www.europub.co.uk/articles/-A-220745